Encysive Pharmaceuticals (ENCY) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Encysive Pharmaceuticals (ENCY)

An SI Board Since November 2005

Posts	SubjectMarks	Bans
205	11	0

Emcee: tuck	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
105	>>too much risk that this was a momentum pile-on. Could be. One of my fr	IRWIN JAMES FRANKEL	-	9/15/2006
104	I looked at it at 4.55 and concluded that there was too much risk that this was	tom pope	-	9/15/2006
103	Count me with ewolf. Big spike in volume. And history suggests that ENCY leaks	IRWIN JAMES FRANKEL	-	9/15/2006
102	I doubt that the spike was due to mf piece. Too much of a stretch to think they	ewolf	-	9/15/2006
101	7% spike on release of Motley Fool piece that only peripherally mentions ENCY, a	tuck	-	9/15/2006
100	The longer Given drags this out without delivering US approval the more likely h	IRWIN JAMES FRANKEL	-	9/14/2006
99	Hire Dolan?	tom pope	-	9/14/2006
98	Oh what ency could have been! Wonder when a. ency will report back from fda, ge	rkrw	-	9/14/2006
97	14-Sep-06 07:46 MYOG Myogen initiated with a Buy at WR Hambrecht- tgt $50 (34.	IRWIN JAMES FRANKEL	-	9/14/2006
96	Mondo/Biogen. I've heard very good things about this one... Press Release S	rkrw	-	9/14/2006
95	Heavy selling in the last hour of trade pushing ENCY down to 4.03. About 1.4M s	IRWIN JAMES FRANKEL	-	9/8/2006
94	It just occurred to me that they might be gunning for off-label use, assuming ap	tuck	-	9/8/2006
93	I think it is an 'expand the market' study and not involved in PAH appro	bio_kruncher	-	9/8/2006
92	Looks like primarily a safety trial to me. My guess is the follow up will be li	kenhott	-	9/8/2006
91	Might this be one of those adaptive trials, where they take an interim look and	tuck	-	9/7/2006
90	So why did MYOG start another study? It looks too small to power conclusions ab	IRWIN JAMES FRANKEL	-	9/7/2006
89	Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients wi	IRWIN JAMES FRANKEL	-	9/7/2006
88	Ya, Tracleer labeled for both class 3 and 4. Thelin wanted class 2 but didn'	kenhott	-	8/24/2006
87	I needed to do some homework. I was wrong about the reproductive issues, in tha	tuck	-	8/24/2006
86	Only Class III - no IV? Tracleer has IV if memory serves. Jon	Robohogs	-	8/24/2006
85	My latest guess is that ENCY is basically fighting over the FDA label. I was in	kenhott	-	8/24/2006
84	Maybe that is the hangup with FDA on approval and they want a trial measuring th	Robohogs	-	8/24/2006
83	not that interesting. deleted.	kenhott	-	8/24/2006
82	From EU label: >3 and <5 × ULN Confirm by another liver test within	kenhott	-	8/24/2006
81	FDA Class 1 response: Label, safety update, minor reanalysis of data, etc. I ha	kenhott	-	8/24/2006

Go to reply# or date (mm/dd/yy):